Filing Flows › Health Care › Cardinal Health (CAH)
Cardinal Health (CAH) earnings and revenue breakdown
Latest: Q1 FY27 · 10-Q filed Nov 5, 2026 · Cardinal Health (CAH) Q1 FY27 earnings results →
Q1 FY27 Revenue up 6% year over year to $67.5B · 1¢ of every $1 of revenue kept as net profit · operating margin 1.1%
Cardinal Health made $67.5B in Q1 FY27 (+6% Y/Y). Operating margin 1.1%, net earnings $556M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Nov 5, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $67.5B in Q1 FY27, up 5% year over year and up 6% from the previous quarter.
Gross margin was 3.8%, up 0.2 points from Q1 FY26. Operating profit was $0.75B, a 1.1% margin (up 0.1 points year over year). Of the extra revenue versus Q1 FY26, 2% reached operating profit, above the 1% margin then. Operating expenses grew 12% against revenue growth of 5%. The fastest-growing cost line was Other operating costs (+31%). Net earnings were $0.55B, up 23% year over year. The effective tax rate was 19.2%.
Operating cash flow was $1.4B (up 44% year over year), 251% of net earnings. Non-cash charges added back $0.25B of depreciation and amortization and $0.11B of share-based compensation. Working capital and other items added $0.49B. Capital expenditures of $0.16B left free cash flow of $1.2B.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q1 FY27 | 10-Q | Nov 5, 2026 | $67.5B | +6% | 1.1% | $556M | $1.4B |
| Q3 FY26 | 10-Q | Apr 30, 2026 | $60.9B | +11% | 0.8% | $380M | $1.8B |
| Q2 FY26 | 10-Q | Feb 5, 2026 | $65.6B | +19% | 1.1% | $471M | $686M |
| Q1 FY26 | 10-Q | Oct 30, 2025 | $64.0B | +22% | 1.0% | $454M | $973M |
| Q4 FY25 | 10-K | Aug 12, 2025 | $60.2B | +0.5% | 0.7% | $243M | $1.5B |
| Q3 FY25 | 10-Q | May 1, 2025 | $54.9B | 0% | 1.3% | $508M | $2.9B |
| Q2 FY25 | 10-Q | Jan 30, 2025 | $55.3B | -4% | 1.0% | $401M | −$396M |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
Customers and suppliers named in filings
Sells to
- CVS — 30% of its revenue · Stated in 10-K (sentence) · source
- SCLX · Stated in 10-K (named, share not stated) · source
Buys from
- PCRX — 26% of the supplier’s revenue · Stated in 10-K (sentence) · source
- ADCT — 22% of the supplier’s revenue · Stated in 10-K (customer table) · source
- BMY — 22% of the supplier’s revenue · Stated in 10-K (XBRL) · source
- CHRS — 20% of the supplier’s revenue · Stated in 10-K (XBRL) · source
- AMPH — 19% of the supplier’s revenue · Stated in 10-K (XBRL) · source
- AMGN — 16% of the supplier’s revenue · Stated in 10-K (XBRL) · source
- ALKS — 15% of the supplier’s revenue · Stated in 10-K (sentence) · source
- BHC — 14% of the supplier’s revenue · Stated in 10-K (customer table) · source
- PFE — 13% of the supplier’s revenue · Stated in 10-K (XBRL) · source
- RIGL — 13% of the supplier’s revenue · Stated in 10-K (customer table) · source
- EXEL — 12% of the supplier’s revenue · Stated in 10-K (customer table) · source
- MRNA — 11% of the supplier’s revenue · Stated in 10-K (XBRL) · source
About Cardinal Health
Cardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an operator of nuclear pharmacies and manufacturing facilities; and a provider of performance and data solutions. Our company's customer-centric focus drives continuous improvement and leads to innovative solutions that improve people's lives every day. Learn more about Cardinal Health at cardinalhealth.com and in our Newsroom .
In its own words, from its 8-K, filed Aug 11, 2026.
Cardinal Health against its Wholesale-Drugs, Proprietaries & Druggists' Sundries peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +6% against the peers' median +5%. Operating margin: 1.1% against the peers' median 1.3%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| CAH Cardinal Health | Q1 FY27 | $67.5B | +6% | 1.1% |
| MCK McKesson | Q2 FY27 | $111.0B | +8% | 1.4% |
| COR Cencora | Q3 FY26 | $84.8B | +5% | 1.3% |
| HLF Herbalife | Q3 2026 | $1.4B | +6% | 10.3% |
| NUS Nu Skin Enterprises | Q3 2026 | $311M | -15% | 1.6% |
| COSM Cosmos Health | Q2 2026 | $19.0M | +29% | -15.4% |
| MEDS DataMeds AI | Q2 2026 | $1.8M | -77% | -412.7% |
| STEK Stemtech | Q2 2026 | $629K | -10% | -20.0% |
| ESYN HWH International | Q2 2026 | $64K | -79% | 328.1% |
Source: Cardinal Health 10-Q on SEC EDGAR · CIK 721371 · Wholesale-Drugs, Proprietaries & Druggists' Sundries
13F: who owns CAH and who is buying
More on CAH
- How Cardinal Health makes money: revenue by segment
- Cardinal Health next earnings date and what analysts expect
- Cardinal Health stock forecast, price target and fair value
- Who owns Cardinal Health stock: holders, funds and Congress trades
- Cardinal Health guidance and outlook
- Is Cardinal Health a takeover target? LBO and rumors
- Cardinal Health recalls, complaints and regulation
History
Every quarter: Q1 FY27 results · Q3 FY26 results · Q2 FY26 results · Q1 FY26 results · Q4 FY25 results · Q3 FY25 results · Q2 FY25 results